45 related articles for article (PubMed ID: 38505696)
41. The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.
Roach M; Land N; Hernandez J; Rau R; Chou JW; Hickson SS; Rollmann DF; Maclean JR
Int J Clin Pract; 2024; 2024():5877687. PubMed ID: 38505696
[TBL] [Abstract][Full Text] [Related]
42. Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care.
Cross AJ; Thomas D; Liang J; Abramson MJ; George J; Zairina E
Cochrane Database Syst Rev; 2022 May; 5(5):CD012652. PubMed ID: 35514131
[TBL] [Abstract][Full Text] [Related]
43. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review.
Fu Y; Chapman EJ; Boland AC; Bennett MI
Palliat Med; 2022 May; 36(5):770-782. PubMed ID: 35311415
[TBL] [Abstract][Full Text] [Related]
44. Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.
Zhang Z; Yang S; Ma Y; Zhou H; Wu X; Han J; Hou J; Hao L; Spicer JD; Koh YW; Provencio M; Reguart N; Mitsudomi T; Wang Q
Transl Lung Cancer Res; 2021 Jun; 10(6):2715-2732. PubMed ID: 34295672
[TBL] [Abstract][Full Text] [Related]
45. Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Burgers JS; Anzueto A; Black PN; Cruz AA; Fervers B; Graham ID; Metersky M; Woodhead M; Yawn BP;
Proc Am Thorac Soc; 2012 Dec; 9(5):304-10. PubMed ID: 23256175
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
